Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone Effect on Alcohol-Induced Dopamine Release
NCT03854942Phase 1Terminated
- Sponsor
- RWTH Aachen University
- Start
- Aug 2011
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of naltrexone in alcohol dependence (3 arms), sponsored by RWTH Aachen University. Primary endpoints: Pharmacological effect of naltrexone on the dopamine synthesis rate at 28 days and Dopamine D2 receptor availability at 28 days. Started Aug 2011; status: terminated.
02
Drugs
naltrexone
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT03854942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03854942.